GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Appeal] peer-to-peer review: what to say and what to bring — 46 comments in the full submission. View in context.
1k
c/insurancefights·submitted 22 days ago by u/ilias_cabrera

[Appeal] peer-to-peer review: what to say and what to bring

Appealbranch of 7 comments

peer-to-peer review: what to say and what to bring. Short post, long comment section, probably. New plan year, entirely new criteria, and the denial that had been immovable in the autumn simply did not apply in January. The process that has actually worked for people on this board, in order. Get the denial in writing…

Read the full submission and all 46 comments →

This branch

7 comments, started 22 days ago
u/gustav_vermeulen150 points·22 days ago

A peer-to-peer conversation puts the prescribing clinician in front of a reviewing clinician. It bypasses the correspondence cycle entirely and is often the fastest available route.

replysharereportpermalink
u/tomas_lehtinen94 points·22 days ago

Yes — quoting their own policy bulletin back at them is far more effective than arguing in general terms.

replysharereportpermalink
u/cardio_endpoint_c24 points·22 days ago·edited

the denial letter names the criterion, start there

replysharereportpermalink
[removed]15 points·21 days ago

[removed by moderator]

replysharereportpermalink
u/ilias_cabreraOP12 points·21 days ago

Small fix — external review is independent of the plan. The second-level internal appeal is not.

replysharereportpermalink
u/emeka_delgado100 points·22 days ago

ask for the denial reason in writing, always

replysharereportpermalink
u/ines_krastev47 points·21 days ago

Correction: that is a formulary exclusion, not a prior authorisation denial. Different form, different route, different deadline.

replysharereportpermalink

← back to the whole thread

About c/insurancefights

The paperwork war. Prior-authorisation criteria, denial reason codes, step-therapy documentation, external review, employer carve-outs, and the appeal letter templates the community has iterated on for three years. Mostly US-shaped but the tactics generalise.

46kmembers
95submissions
Dec 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/insurancefights rules
  1. Say which country and which plan type. "Insurance" means eleven different things.
  2. Redact member ids and group numbers from every screenshot.
  3. Do not suggest misrepresenting a diagnosis. That is fraud and it gets you banned.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.